These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis. Wakasa Y, Takagi H, Hirose S, Yang L, Saeki M, Nishimura T, Kaminuma O, Hiroi T, Takaiwa F. Plant Biotechnol J; 2013 Jan; 11(1):66-76. PubMed ID: 23066780 [Abstract] [Full Text] [Related]
3. T-cell activation by transgenic rice seeds expressing the genetically modified Japanese cedar pollen allergens. Takaishi S, Saito S, Endo T, Asaka D, Wakasa Y, Takagi H, Ozawa K, Takaiwa F, Otori N, Kojima H. Immunology; 2019 Oct; 158(2):94-103. PubMed ID: 31323138 [Abstract] [Full Text] [Related]
5. Safety and efficacy of rice seed-based oral allergy vaccine for Japanese cedar pollinosis in Japanese monkeys. Saito S, Takagi H, Wakasa Y, Ozawa K, Takaiwa F. Mol Immunol; 2020 Sep; 125():63-69. PubMed ID: 32650161 [Abstract] [Full Text] [Related]
9. Recombinant Fusion Allergens, Cry j 1 and Cry j 2 from Japanese Cedar Pollen, Conjugated with Polyethylene Glycol Potentiate the Attenuation of Cry j 1-Specific IgE Production in Cry j 1-Sensitized Mice and Japanese Cedar Pollen Allergen-Sensitized Monkeys. Fujimura T, Fujinami K, Ishikawa R, Tateno M, Tahara Y, Okumura Y, Ohta H, Miyazaki H, Taniguchi M. Int Arch Allergy Immunol; 2015 Sep; 168(1):32-43. PubMed ID: 26524293 [Abstract] [Full Text] [Related]
10. Development of transgenic rice seed accumulating a major Japanese cedar pollen allergen (Cry j 1) structurally disrupted for oral immunotherapy. Yang L, Suzuki K, Hirose S, Wakasa Y, Takaiwa F. Plant Biotechnol J; 2007 Nov; 5(6):815-26. PubMed ID: 17714439 [Abstract] [Full Text] [Related]
12. Peptide immunotherapy for allergic diseases using a rice-based edible vaccine. Hiroi T, Takaiwa F. Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):455-60. PubMed ID: 17088651 [Abstract] [Full Text] [Related]
13. A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses. Takagi H, Hiroi T, Yang L, Tada Y, Yuki Y, Takamura K, Ishimitsu R, Kawauchi H, Kiyono H, Takaiwa F. Proc Natl Acad Sci U S A; 2005 Nov 29; 102(48):17525-30. PubMed ID: 16278301 [Abstract] [Full Text] [Related]
14. Reduced anaphylactic potential of denatured pullulan-conjugated Cry j 1. Utsumi D, Sugawara T, Hashida K, Yasuhara Y, Fujinami K, Lund K, Ohashi-Doi K. Int Immunopharmacol; 2021 Oct 29; 99():108026. PubMed ID: 34358858 [Abstract] [Full Text] [Related]
15. Effect of Cry-consensus peptide, a novel recombinant peptide for immunotherapy of Japanese cedar pollinosis, on an experimental allergic rhinitis model in B10.S mice. Tsunematsu M, Yamaji T, Kozutsumi D, Murakami R, Kimura S, Kino K. Allergol Int; 2007 Dec 29; 56(4):465-72. PubMed ID: 17965586 [Abstract] [Full Text] [Related]
16. Development of a rice-based peptide vaccine for Japanese cedar and cypress pollen allergies. Takaiwa F, Yang L. Transgenic Res; 2014 Aug 29; 23(4):573-84. PubMed ID: 24638148 [Abstract] [Full Text] [Related]
17. Efficacy of oral immunotherapy with a rice-based edible vaccine containing hypoallergenic Japanese cedar pollen allergens for treatment of established allergic conjunctivitis in mice. Fukuda K, Ishida W, Harada Y, Wakasa Y, Takagi H, Takaiwa F, Fukushima A. Allergol Int; 2018 Jan 29; 67(1):119-123. PubMed ID: 28676431 [Abstract] [Full Text] [Related]
20. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells. Masuda K. Vet Immunol Immunopathol; 2005 Oct 18; 108(1-2):185-7. PubMed ID: 16098609 [Abstract] [Full Text] [Related] Page: [Next] [New Search]